DA32 Life Science Tech Acquisition Corp.

DA32 Life Science Tech Acquisition Corp. (Nasdaq: DALS) is a blank-check company formed to pursue a business combination in the life sciences and healthcare technology sector. The company filed a Form 10-Q with the SEC on May 12, 2023, under accession number 0001193125-23-143535, reflecting its status as an active shell company conducting its search for a target. DALS is among the cohort of sector-focused SPACs that emerged during the concentrated wave of life science SPAC activity in the early 2020s, targeting companies at the intersection of biotechnology, diagnostics, and health technology. Visit SpacDesk and sign up for full access to DALS filings, deal timelines, and comparable SPAC data.